Aimco Pesticides Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 3 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹48 Cr
FY26 revenue target: Approximately ₹225 crore, reflecting a cautious growth approach. Aimco Pesticides targets a cautious 10% revenue growth for FY26, aiming for a top line around ₹225 crore.
From Aimco Pesticides Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹47.2
Market Cap
₹48 Cr
Revenue Rank
Margin Rank
How does Aimco Pesticides Ltd rank in Fertilizers & Agrochemicals?
Compare Aimco Pesticides Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Aimco Pesticides Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹30 Cr, net profit ₹-3 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →FY26 revenue target: Approximately ₹225 crore, reflecting a cautious growth approach.
- →Aimco expects to remain profitable in FY26, focusing on positive EBITDA rather than aggressive topline growth.
- →Brand sale formulation business targeted for 20% year-on-year growth.
- →Increased production capacity and tie-ups enhance formulation brand sales capacity.
- →New molecules launched and under registration to drive next-year volume growth, especially in technical manufacturing.
- →Volume growth observed in active ingredients (~25%), but value growth constrained due to price declines.
- →Expansion plans include new markets (e.g., Brazil, Australia, Indonesia, US) and new product additions.
- →Existing bulk formulation sales rising (from 9% in 2023 to 24% in 2025), but company aims to limit bulk sales focus in favor of brand sale profitability.
- →Inventory levels being optimized to improve operational efficiency.
📈 Profitability & Margins
Rank 3- →Aimco Pesticides targets a cautious 10% revenue growth for FY26, aiming for a top line around ₹225 crore.
- →The primary focus for FY26 is to achieve profitability and avoid negative EBITDA after two challenging years.
- →Gross margins are expected to remain modest; no significant margin expansion anticipated in the near term.
- →Brand sale formulation business is seen as a key growth driver, targeting 20% growth with gross margins around 30-35%.
- →New molecules started manufacturing provide potential for volume growth and improved profitability from FY26 onwards.
- →Bulk formulation business growth is opportunistic but limited to maintain focus on profitability.
- →The company is working on cost reduction and operational efficiencies to improve margins.
- →EPS improvement aligned with achieving positive net profits; however, PAT might remain negative in the near term but aims at profitability by FY26.
🏗️ Capital Expenditure Plans
Yes- →Aimco Pesticides has CapEx plans to increase production capacity for two new molecules already started.
- →No specific timeline set for the execution of these CapEx plans; implementation will be based on customer negotiations and confirmed business volumes.
- →Other planned CapEx includes small investments focused on safety improvements and debottlenecking existing processes.
- →Capital infusion has been made by promoters through a preferential issue of 2 lakh shares to support operations and growth.
- →The company is cautious about growth to maintain profitability and is closely managing costs and margins amid market challenges.
💰 Fundraising & Capital Structure
No information- →The transcript does not mention any current or future fundraising plans through debt or equity.
- →However, it is noted that promoters have infused additional capital into the company through a preferential issue of 2 lakh shares to support operations and growth initiatives.
- →No specific details about any new debt or equity fundraising programs, timelines, or amounts are provided.
- →The focus remains on cost reduction, margin improvement, and cautious growth without mentioning external fund raising plans.
📋 Order Book & Pipeline
No information- →The company is actively pursuing bulk formulation business opportunities, especially with a new molecule started last year that has good potential for B2B and brand sales.
- →Current volumes with UPL are growing, with the plant running at almost full capacity and expectations of even higher volumes this year.
- →Discussions are ongoing with UPL for new molecules, though timelines and commercializations are uncertain.
- →They have started initial orders and tie-ups in Brazil for products like Bifenthrin formulation and Triclopyr, with expected sales of around 200-300 tons for Triclopyr in Brazil (~₹100 crore value).
- →New molecules under registration in various countries and pilot trials are ongoing.
- →No specific numeric order book was mentioned, but the company targets ₹225 crore revenue in FY26, focusing on profitable growth rather than aggressive scaling.
- →The company is cautious and focused on margin improvement alongside volume growth.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Aimco Pesticides Ltd Q4 FY25 results?
FY26 revenue target: Approximately ₹225 crore, reflecting a cautious growth approach. Aimco Pesticides targets a cautious 10% revenue growth for FY26, aiming for a top line around ₹225 crore.
What is Aimco Pesticides Ltd share price analysis?
Aimco Pesticides Ltd currently shows a below-average growth signal. The stock trades at a P/E of N/A with a market cap of ₹48 Cr. Investors should review the full earnings analysis for detailed insights.
Is Aimco Pesticides Ltd planning capital expenditure?
Aimco Pesticides has CapEx plans to increase production capacity for two new molecules already started.
Keep Aimco Pesticides Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.